Is There a Role for Immunotherapy in Central Nervous System Cancers?

被引：5
|
作者：
Flores, Catherine [1 ]
Dunn, Gavin [2 ]
Fecci, Peter [3 ]
Lim, Michael [4 ]
Mitchell, Duane [1 ]
Reardon, David A. [5 ,6 ]
机构：
[1] Univ Florida Hlth, JR Ctr Brain Tumor Therapy, Dept Neurosurg, 1505 Southwest Archer Rd, Gainesville, FL 32608 USA
[2] Washington Univ, Ctr Human Immunol & Immunotherapy Programs, Neurol & Pathol Immunol, Sch Med, 660 South Euclid,Campus Box 8057, St Louis, MO 63110 USA
[3] Duke Univ, Dept Neurosurg, Med Ctr, 20 Duke Med Circle, Durham, NC 27710 USA
[4] Stanford Univ, Dept Neurosurg, Sch Med, 453 Quarry Rd,Neurosurg 5327, Palo Alto, CA USA
[5] Harvard Med Sch, Boston, MA 02115 USA
[6] Dana Farber Canc Inst, Ctr Neurooncol, 450 Brookline Ave, Boston, MA 02215 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2022年 / 36卷 / 01期
关键词：
Glioblastoma; Immunotherapy; Immune checkpoint; Adoptive cellular therapy; Vaccines; Immunosuppression; REGULATORY T-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; PRIMARY INTRACRANIAL TUMORS; IMMUNE CHECKPOINT BLOCKADE; LONG-TERM SURVIVAL; HUMAN CYTOMEGALOVIRUS; ACQUIRED-RESISTANCE; MISMATCH REPAIR; CLINICAL-TRIAL; GLIOBLASTOMA;
D O I：
10.1016/j.hoc.2021.09.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：237 / 252
页数：16
相关论文
共 50 条
  • [31] Liver Graft Procurement in Donors with Central Nervous System Cancers
    Detry, Olivier
    LIVER TRANSPLANTATION, 2010, 16 (07) : 914 - 915
  • [32] Immunotherapy for cancer in the central nervous system: Current and future directions
    Binder, David C.
    Davis, Andrew A.
    Wainwright, Derek A.
    ONCOIMMUNOLOGY, 2016, 5 (02):
  • [33] Nanomedicine-based immunotherapy for central nervous system disorders
    Hanif, Sumaira
    Muhammad, Pir
    Chesworth, Rose
    Rehman, Fawad Ur
    Qian, Rong-jun
    Zheng, Meng
    Shi, Bing-yang
    ACTA PHARMACOLOGICA SINICA, 2020, 41 (07) : 936 - 953
  • [34] Central nervous system infections -: a potential complication of systemic immunotherapy
    Hemmer, B
    Frohman, E
    Hartung, HP
    Stüve, O
    CURRENT OPINION IN NEUROLOGY, 2006, 19 (03) : 271 - 276
  • [35] Nanomedicine-based immunotherapy for central nervous system disorders
    Sumaira Hanif
    Pir Muhammad
    Rose Chesworth
    Fawad Ur Rehman
    Rong-jun Qian
    Meng Zheng
    Bing-yang Shi
    Acta Pharmacologica Sinica, 2020, 41 : 936 - 953
  • [36] Emerging Landscape of Immunotherapy for Primary Central Nervous System Lymphoma
    Alcantara, Marion
    Fuentealba, Jaime
    Soussain, Carole
    CANCERS, 2021, 13 (20)
  • [37] Distinct roles of TREM2 in central nervous system cancers and peripheral cancers
    Zhong, Jian
    Xing, Xudong
    Gao, Yixin
    Pei, Lei
    Lu, Chenfei
    Sun, Huixin
    Du, Kang
    Xiao, Feizhe
    Lai, Yanxing
    Yang, Ying
    Wang, Xiuxing
    Shi, Yu
    Bai, Fan
    Zhang, Nu
    CANCER CELL, 2024, 42 (06) : 968 - 984.e9
  • [38] The Role of the GABAergic System in Diseases of the Central Nervous System
    Zhang, Wen
    Xiong, Bing-Rui
    Zhang, Long-Qing
    Huang, Xian
    Yuan, Xiaoman
    Tian, Yu-Ke
    Tian, Xue-Bi
    NEUROSCIENCE, 2021, 470 : 88 - 99
  • [39] The Financial Burden of Central Nervous System Cancers in the United States The Financial Burden of Central Nervous System Cancer in the United States
    Pena, Miren
    Mendonca, Chelsea
    Siddiqui, Mehdi
    Hegde, Sheetal
    Seifi, Ali
    NEUROLOGY, 2019, 92 (15)
  • [40] Role of the Immune System in the Development of the Central Nervous System
    Morimoto, Keiko
    Nakajima, Kazunori
    FRONTIERS IN NEUROSCIENCE, 2019, 13
12345